Literature DB >> 22540887

Risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients undergoing screening colonoscopy.

B Lebwohl1, K Capiak, A I Neugut, F Kastrinos.   

Abstract

BACKGROUND: Racial and ethnic differences in the risk of premalignant colorectal neoplasia have not been extensively studied. AIM: To measure adenoma prevalence among asymptomatic white, black and Hispanic patients undergoing screening colonoscopy.
METHODS: In this cross sectional cohort study, data from individuals ≥50 years undergoing first-time colonoscopy since 2006 at a single tertiary-care medical centre were obtained from the electronic medical record. Adenoma prevalence among whites, blacks and Hispanics was calculated; multivariate Poisson and logistic regression were used to identify factors independently associated with adenoma rates and the presence of advanced adenomas.
RESULTS: We identified 5075 eligible subjects: 3542 (70%) whites, 942 (18%) Hispanics and 591 (12%) blacks. The mean age was 62.2 years with 58% women. At least one adenoma was detected in 19%, 22% and 26% of whites, Hispanics and blacks respectively (Hispanics vs. whites P = 0.09; blacks vs. whites P = 0.0001). Isolated proximal adenomas were present in 9% of whites, 11% of Hispanics (P = 0.03) and 11% of blacks (P = 0.03). In multivariate analyses, a higher rate of adenomas was present in Hispanics (RR: 1.37, 95% CI: 1.20-1.57) and blacks (RR: 1.76, 95% CI: 1.52-2.04) than whites. Hispanics and blacks also had an increased risk of advanced adenomas compared to whites (OR(Hispanics) : 2.25, 95% CI: 1.62-3.11; OR(blacks) : 1.91, 95% CI: 1.27-2.86).
CONCLUSIONS: Adenoma prevalence was higher in blacks and Hispanics than in whites. Both groups were at greater risk of having proximal adenomas in the absence of any distal pathology than whites, where these lesions would have only been detected by colonoscopy. Efforts to promote screening are necessary among diverse, under-represented populations.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22540887      PMCID: PMC3396558          DOI: 10.1111/j.1365-2036.2012.05119.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  11 in total

1.  Cancer survival among Latinos and the Hispanic Paradox.

Authors:  Paulo S Pinheiro; Melanie Williams; Eric A Miller; Stephanie Easterday; Sheniz Moonie; Edward J Trapido
Journal:  Cancer Causes Control       Date:  2011-01-29       Impact factor: 2.506

2.  Effect of a patient navigator program on the volume and quality of colonoscopy.

Authors:  Benjamin Lebwohl; Alfred I Neugut; Eliezer Stavsky; Sonia Villegas; Corinne Meli; Orlando Rodriguez; Carmen Franco; Marian S Krauskopf; Richard Rosenberg
Journal:  J Clin Gastroenterol       Date:  2011 May-Jun       Impact factor: 3.062

Review 3.  Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy.

Authors:  C Hassan; P J Pickhardt; D H Kim; E Di Giulio; A Zullo; A Laghi; A Repici; F Iafrate; J Osborn; B Annibale
Journal:  Aliment Pharmacol Ther       Date:  2009-10-08       Impact factor: 8.171

4.  Prevalence of colon polyps detected by colonoscopy screening of asymptomatic Hispanic patients.

Authors:  Brent Lee; Jennifer Holub; Dawn Peters; David Lieberman
Journal:  Dig Dis Sci       Date:  2011-09-15       Impact factor: 3.199

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos.

Authors:  Paulo S Pinheiro; Recinda L Sherman; Edward J Trapido; Lora E Fleming; Youjie Huang; Orlando Gomez-Marin; David Lee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

7.  Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States.

Authors:  David A Lieberman; Jennifer Holub; Glenn Eisen; Dale Kraemer; Cynthia D Morris
Journal:  Clin Gastroenterol Hepatol       Date:  2005-08       Impact factor: 11.382

8.  Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients.

Authors:  David A Lieberman; Jennifer L Holub; Matthew D Moravec; Glenn M Eisen; Dawn Peters; Cynthia D Morris
Journal:  JAMA       Date:  2008-09-24       Impact factor: 56.272

9.  Colon pathology detected after a positive screening flexible sigmoidoscopy: a prospective study in an ethnically diverse cohort.

Authors:  Fritz Francois; James Park; Edmund J Bini
Journal:  Am J Gastroenterol       Date:  2006-02-22       Impact factor: 10.864

10.  Cancer patterns of four ethnic groups in Hawaii.

Authors:  L N Kolonel
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

View more
  34 in total

1.  Assessing bowel preparation quality using the mean number of adenomas per colonoscopy.

Authors:  Grace Clarke Hillyer; Benjamin Lebwohl; Richard M Rosenberg; Alfred I Neugut; Randi Wolf; Corey H Basch; Jennie Mata; Edwin Hernandez; Douglas A Corley; Steven Shea; Charles E Basch
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.

Authors:  Muneer J Al-Husseini; Anas M Saad; Khalid A Jazieh; Abdelmagid M Elmatboly; Ahmad Rachid; Mohamed M Gad; Inas A Ruhban; Talal Hilal
Journal:  Int J Colorectal Dis       Date:  2018-11-15       Impact factor: 2.571

3.  Ethnic variations in the occurrence of colonic neoplasms.

Authors:  Amnon Sonnenberg; Kevin O Turner; Robert M Genta
Journal:  United European Gastroenterol J       Date:  2016-08-24       Impact factor: 4.623

4.  Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older Patients.

Authors:  Kristin Wallace; Allan DeToma; David N Lewin; Shaoli Sun; Don Rockey; Carolyn D Britten; Jennifer D Wu; Aissatou Ba; Anthony J Alberg; Elizabeth G Hill
Journal:  Clin Colorectal Cancer       Date:  2016-12-07       Impact factor: 4.481

5.  Physician characteristics associated with higher adenoma detection rate.

Authors:  Ateev Mehrotra; Michele Morris; Rebecca A Gourevitch; David S Carrell; Daniel A Leffler; Sherri Rose; Julia B Greer; Seth D Crockett; Andrew Baer; Robert E Schoen
Journal:  Gastrointest Endosc       Date:  2017-09-01       Impact factor: 9.427

6.  Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina.

Authors:  Kristin Wallace; Heather M Brandt; James D Bearden; Bridgette F Blankenship; Renay Caldwell; James Dunn; Patricia Hegedus; Brenda J Hoffman; Courtney H Marsh; William H Marsh; Cathy L Melvin; March E Seabrook; Ronald E Sterba; Mary Lou Stinson; Annie Thibault; Franklin G Berger; Anthony J Alberg
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

7.  Colorectal neoplasia detection among black and Latino individuals undergoing screening colonoscopy: a prospective cohort study.

Authors:  Kristen K Lee; Lina Jandorf; Linda Thélèmaque; Steven H Itzkowitz
Journal:  Gastrointest Endosc       Date:  2014-03       Impact factor: 9.427

8.  The association of age and race and the risk of large bowel polyps.

Authors:  Kristin Wallace; Carol A Burke; Dennis J Ahnen; Elizabeth L Barry; Robert S Bresalier; Fred Saibil; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-09       Impact factor: 4.254

9.  Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.

Authors:  Uri Ladabaum; Ajitha Mannalithara; Lina Jandorf; Steven H Itzkowitz
Journal:  Cancer       Date:  2014-12-09       Impact factor: 6.860

10.  Differences in Prevalence of Large Polyps Between Hispanic Americans from Mexican- and Non-Mexican-Predominant States.

Authors:  Danny J Avalos; Marc J Zuckerman; Alok Dwivedi; Christopher Dodoo; Jinendra Satiya; Fernando J Castro
Journal:  Dig Dis Sci       Date:  2018-10-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.